Skip to main content
OpenTrials

Clinical trial condition

Relapsed /Refractory DLBCL

Explore clinical trials studying Relapsed /Refractory DLBCL. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Relapsed /Refractory DLBCL trial results

Not Yet Recruiting

Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

NCT07634289

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Townsville University Hospital Douglas, Queensland, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • Flinders Medical Centre Bedford Park, South Australia, Australia
  • Austin Hospital Heidelberg, Victoria, Australia
View Trial Details
Not Yet Recruiting

Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept

NCT07542678

Conditions
Relapsed /Refractory DLBCL
Locations
  • Universitätsklinikum Heidelberg - Innere Medizin V Heidelberg, Baden-Wurttemberg, Germany
  • Universitätsklinikum Düsseldorf - Klinik für Hämatologie, Onkologie und klinische Immunologie Düsseldorf, North Rhine-Westphalia, Germany
  • Universitätsklinikum Essen (AöR) - Westdeutsches Tumorzentrum Essen - Klinik für Hämatologie und Stammzellltransplantation Essen, North Rhine-Westphalia, Germany
  • Universitätsklinikum Münster - Medizinische Klinik A Münster, North Rhine-Westphalia, Germany
View Trial Details

Related conditions